Catalyst
Slingshot members are tracking this event:
Decision on Lilly's (LLY) Olaratumab in Soft Tissue Sarcoma Expected From European Medicines Agency By End of November
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LLY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 19, 2016
Occurred Source:
https://investor.lilly.com/releasedetail.cfm?ReleaseID=994445
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Olaratumab, Soft Tissue Sarcoma, European Medicines Agency, Chmp
